COPD
Below is a sample of existing clinical evidence:“Autologous cell therapy in patients having chronic obstructive pulmonary disease is a safe procedure and free of adverse effects. There was an improvement in laboratory parameters (spirometry) and a slowing down in the process of pathological degeneration. Also, patients reported improvements in the clinical condition and quality of life.”
– “Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years,” Stessuk et al, Revista Brasileira de Hematologia e Hemoterapia, 2013
For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).